       Document 0478
 DOCN  M9640478
 TI    Rethinking CD4+ T cell counts for individuals who recently seroconverted
       to human immunodeficiency virus.
 DT    9604
 AU    Weiss PJ; Wallace MR; Department of Internal Medicine, Naval Medical
       Center, San Diego,; California, USA.
 SO    Clin Infect Dis. 1995 Sep;21(3):666-8. Unique Identifier : AIDSLINE
       MED/96077394
 AB    The distribution of initial CD4+ T lymphocyte counts for individuals who
       have recently seroconverted to human immunodeficiency virus (HIV) is
       broad. We review major articles describing CD4 cell counts shortly after
       documented HIV infection and discuss both the possible sources of
       variability in these studies and the clinical importance of recognizing
       that even recently infected patients may have low CD4 cell counts and
       thus will require therapeutic intervention with antiretroviral agents or
       prophylactic antibiotics.
 DE    Antibiotics/THERAPEUTIC USE  Antiviral Agents/THERAPEUTIC USE  *CD4
       Lymphocyte Count  Human  HIV Seropositivity/DRUG THERAPY/*IMMUNOLOGY
       Time Factors  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

